European Austerity Drama May Likely Spur The Pace But Not Change The Strategic Plot Line For Pharma
By
Melanie Senior / Email the Author / “The Pink Sheet” Dec. 5, 2011, Vol. 73, No. 49
Business & Finance / Word Count: 2027 / Article # 00111205005
Executive Summary
Price cuts and austerity measures made 2011 a bleak year for European pharma. These dynamics are more severe but not new, and likely will accelerate firms’ existing geographic expansion and market access strategies.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.